Back to School: How biopharma can reboot drug development. Access exclusive analysis here

IVDMIA draft guidance generates comments

The comment period on FDA's revised draft guidance for in vitro diagnostic multivariate index assays (IVDMIAs) ended Aug. 27 and

Read the full 200 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE